Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

BACKGROUND: Chronic lung infection with Pseudomonas aeruginosa occurs in approximately 50% of patients with cystic fibrosis (CF). This infection further compromises lung function, and significantly contributes to the increased healthcare costs. OBJECTIVES: Inhaled tobramycin, used to manage P. aerug...

Descripción completa

Detalles Bibliográficos
Autores principales: Panguluri, Srilekha, Gunda, Praveen, Debonnett, Laurie, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509782/
https://www.ncbi.nlm.nih.gov/pubmed/28643178
http://dx.doi.org/10.1007/s40261-017-0537-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509782/
https://www.ncbi.nlm.nih.gov/pubmed/28643178
http://dx.doi.org/10.1007/s40261-017-0537-9

Ejemplares similares